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 The term neglected tropical diseases (NTDs) describes a 
disparate group of diseases which affect populations living in 
poverty and are important causes of morbidity and mortality 
worldwide. Global programmes for the control of NTDs benefit 
large-scale donations made by pharmaceutical companies. A 
number of NTDs have internationally agreed targets for their 
control, elimination and eradication. Eradication is defined as 
the permanent reduction to zero of the worldwide incidence 
of infection. Elimination is defined as the reduction to zero 
of the incidence of infection in a specified geographic area. 
Considerable progress has been made towards elimination 
and eradication of some NTDs but unexpected new challenges 
have emerged which threaten the eventual achievement of 
these goals. 
 Neglected tropical diseases 
 In the early 2000s the term neglected tropical diseases (NTDs) 
emerged to describe a disparate group of diseases which 
disproportionately affect populations living in poverty; cause 
important morbidity and mortality – including stigma and 
discrimination – in such populations, justifying a global response; 
are amenable to broad control, elimination or eradication through 
mass treatment, intensified or innovative case management, vector 
control or veterinary public health; and are relatively neglected 
by research. 1,2 The World Health Organization (WHO) currently 
recognises 20 diseases which meet these criteria (Table  1 ). 
 NTD programmes benefit from some of the largest 
pharmaceutical donation programmes ever made. Several 
pharmaceutical companies agreed to donate unlimited supplies 
of medication for as long as it was needed to support global 
programmes. These donations, supported by substantial funds for 
implementation from partners, including the UK Department for 
International Development, have allowed substantial progress to 
be made in reducing morbidity from these conditions. 3 Despite 
this progress, considerable challenges remain in the control, 
elimination and eradication of NTDs. In this article we outline the 
principles of disease elimination and eradication as they apply 
to NTD programmes and illustrate some of the challenges in 
achieving the aim of disease eradication. 
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 Principles of elimination and eradication 
 A common feature of many of the NTDs is the existence of 
international targets for their control, elimination and eradication 
(see Table  1 ). These terms are often used interchangeably and 
sound similar but in fact have specific definitions. The terms were 
first well defined at the Dahlem Workshop in 1997. 4 
 Eradication is defined as the permanent reduction to zero of 
the worldwide incidence of infection. Elimination is defined as 
the reduction to zero of the incidence of infection in a specified 
geographic area. These definitions also highlight other important 
points. Firstly, eradication is by definition a global term – a 
disease cannot be eradicated at the national level. Secondly, even 
following elimination of a disease, ongoing control efforts are 
required to avoid re-introduction. For example, polio has been 
eliminated in the Americas but vaccination is still required until the 
goal of global eradication is achieved. 
 The Dahlem Workshop also highlighted criteria to be considered 
when assessing the feasibility of disease eradication. These criteria 
consist of both biological and political factors and are outlined in 
Table  2 . 
 Key points 
 There are 20 conditions currently recognised by the World 
Health Organization as neglected tropical diseases 
 Ten of these diseases are targeted for either elimination or 
eradication 
 Considerable progress has been made towards guinea worm 
eradication but the occurrence of disease in dogs is a major 
challenge to its eventual eradication 
 Mass treatment with azithromycin is a promising strategy for the 
eradication of yaws but drug resistance is a significant concern 
 Progress has been made towards the control, elimination and 
eradication of many neglected tropical diseases supported by 
large scale drug donations 
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 A number of NTDs have neither an ‘eradication’ nor an 
‘elimination’ target. Instead they have a target of ‘elimination as 
a public health problem’. This term is not well defined but broadly 
can be considered to mean reduction in the prevalence and/or 
incidence of a disease to such a level that it no longer contributes 
significantly to morbidity (or mortality) at the population level. The 
closeness of the terms ‘elimination as a public health problem’ and 
‘elimination’ risks creating confusion in the minds of policymakers 
for whom the terms may appear to be analogous. This risk 
is compounded by the absence of a standard definition for 
‘elimination as a public health problem’ – instead the definitions 
used vary between disease programmes. The targets for each 
disease have also tended to shift over time most commonly from 
less challenging (elimination) to more challenging (eradication) 
targets. 
 The London Declaration 
 Individual targets for neglected tropical disease eradication and 
elimination have emerged over a period of years. In 2012, WHO 
published a roadmap for neglected tropical diseases 5 and this 
was followed by a landmark meeting in London which culminated 
in the ‘London Declaration’ for neglected tropical diseases. 
This meeting bought together policymakers, pharmaceutical 
companies, non-governmental organisations and academics to 
agree a common set of disease targets and priorities. 
 Progress and challenges – case studies in NTD 
eradication 
 Guinea worm 
 Guinea worm disease is caused by infection with  Dracunculus 
medinensis. Infection occurs when humans ingest contaminated 
water containing cyclops (microscopic crustaceans) which act as 
vectors for the Guinea worm larvae. Once in the digestive tract, 
larvae escape from the cyclops and penetrate the subcutaneous 
soft tissues where they mate. Over the following year, the female 
 Table 1.  The World Health Organization neglected 
tropical diseases 
Neglected tropical 
diseases 
Control strategy Elimination 
target 
Schistosomiasis MDA (praziquantel), 
sanitation, snail 
control
Yes (in China)
Onchocerciasis MDA (ivermectin), 
vector control
Yes (in 
Americas)
Lymphatic filariasis MDA (ivermectin, 
albendazole), 
vector control
Yes
Trachoma MDA (azithromycin), 
water, sanitation, 
education
Yes
Yaws MDA 
(azithromycin)
Yes – 
eradication
Soil transmitted helminths MDA (albendazole) No
Guinea worm Safe water, health 
education
Yes – 
eradication
African trypanosomiasis Case finding and 
treatment, vector 
control
Yes (for 
 Trypanosoma 
brucei 
gambiense )
Visceral leishmaniasis Case finding and 
treatment
Yes 
(subcontinent)
Leprosy Case finding and 
treatment
Yes
Taeniasis/cysticercosis Sanitation, 
meat inspection, 
vaccination of pigs
No
Echinococcosis Abbattoir control, 
treatment of dogs, 
education
No
Foodborne trematodes Treatment of 
sheep, health 
education
No
Chagas disease Vector control, 
blood screening
Yes (some 
countries)
Buruli ulcer Case finding and 
treatment
No
Rabies Vaccination of 
dogs, health 
education
No
Dengue and chikungunya Vector control No
Mycetoma Case finding and 
treatment
No
Scabies Not yet defined. 
Possibly MDA 
(ivermectin)
No
Snakebite Not yet defined No
 MDA = mass drug administration. 
 Table 2:  Criteria and requirements for disease 
elimination and eradication 
Biological criteria Social and political criteria 
Availability of an effective 
intervention ie a drug or 
vaccine.
Disease must be recognised to 
be of public health importance.
Diagnostic test with 
adequate sensitivity and 
specificity.
Eradication must be widely 
perceived to be a worthy goal.
Absence of an environmental 
or animal reservoir.
Technically feasible intervention 
must be found to be effective in 
a geographical region.
Political commitment must 
be gained at the highest level 
including potentially a World 
Health Assembly resolution.
There must be an advocacy 
plan for the global, regional and 
national level.
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azithromycin for the treatment of yaws, WHO developed a revised 
strategy for the eradication of yaws (the Morges strategy). This 
strategy emphasises an initial round of MDA using azithromycin 
in endemic communities. Following this it may be appropriate 
to conduct further MDA or to switch to a strategy of treating 
active cases and their contacts (total targeted treatment). 17 
Initial assessments of the efficacy of azithromycin MDA were 
conducted in both the Pacific and west Africa and demonstrated 
considerable impact of MDA on the prevalence of yaws. However, 
despite these initial successes, interruption of transmission 
was not achieved. 18–20 Furthermore resistance to azithromycin 
emerged in the pilot study in Papua New Guinea. Although 
subsequent treatment with benzathine benzylpenicillin was used 
to successfully ring-fence this outbreak, these data highlight 
the risk of emerging azithromycin resistance threatening yaws 
eradication efforts. 21 
 Finally, there is also evidence that non-human primates are also 
infected with  Treponema pallidum subsp  pertenue . 22,23 While no 
evidence currently exists for zoonotic transmission, the existence 
of a possible animal reservoir highlights the challenges that may 
emerge during an eradication campaign. 
 Conclusions 
 Enormous progress has been made towards the control, 
elimination and eradication of neglected tropical diseases. 
These achievements have been based on unprecedented levels 
of support from pharmaceutical companies, governments and 
private donors. Despite this, challenges remain towards the 
eventual attainment of the London Declaration 2020 targets 
and the eventual elimination and eradication of these diseases 
remains uncertain. ■ 
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worms migrate to the legs and feet where a small painful blister 
forms and the worm emerges. It then releases its larvae into water 
sources allowing the cycle of infection to repeat. 
 In the 1980s, the control and eventual elimination of Guinea 
worm were adopted as targets by the World Health Assembly 
(WHA) as part of the United Nation’s International Drinking 
Water Supply and Sanitation decade. 6 In 1991, the WHA formally 
committed to global eradication of Guinea worm. 7 
 The strategy for eradication is based primarily on behaviour 
change. Health education, combined with filter distribution, 
vector control, safe water provision and case containment, 
enables affected communities to break the cycle of transmission. 8 
These methods, spearheaded by the Carter Center, have had 
considerable success. In 1986, there were an estimated 3.5 million 
cases in 20 countries; 9 in 2017 only 30 cases of Guinea worm were 
reported in two countries, Ethiopia and Chad. 10 
 Despite the progress, significant challenges remain. Continuing 
civil war in South Sudan has disrupted surveillance activities. 
Following 19 consecutive months without a case being reported, 
three have been detected there since May 2018. 11 Chad remains 
a reservoir of the disease largely due to the significant number 
of cases in dogs, 830 of which were detected in 2017. 10 The 
hypothesised model of transmission in dogs involves consumption 
of Guinea worm larvae contained in the fresh entrails of fish. 12 
Finally, the recent discovery of a human case of Guinea worm in 
Angola, a country that has never previously documented a case of 
the disease, serves as a reminder of the surprises that eradication 
programmes can produce. 11 The source of the worm, identified 
in April 2018, remains a mystery and extensive investigations are 
ongoing. These developments call the imminent success of the 
eradication programme into question. 
 Yaws 
 Yaws, caused by  Treponema pallidum subsp  pertenue, is one 
of two NTDs currently targeted for global eradication. Yaws is 
closely related to syphilis but predominantly affects children living 
in remote tropical communities. If untreated the disease may 
cause destructive and disfiguring lesions of the skin, bones and 
soft tissues. During the mid-twentieth century the disease was 
widespread throughout the tropics and was considered a major 
public health problem. 13,14 
 In 1949, the WHA passed a resolution supporting efforts for 
the control and elimination of yaws. Between 1952 and 1962, 
WHO and the United Nations International Children’s Emergency 
Fund led a joint global campaign to eradicate yaws. 14 More than 
300 million individuals were assessed as part of the campaign and 
more than 50 million treated, a monumental effort at the time. 
However, these efforts were ultimately not successful. Whilst the 
programme did significantly reduce the global prevalence of yaws, 
by as much as 98%, the incidence of the disease rebounded in 
a number of countries in the 1970s. Interest in yaws eradication 
then waned and the disease fell off the global health agenda. 
Interest in yaws eradication was restarted by a landmark study 
conducted in Papua New Guinea which demonstrated that a 
single oral dose of azithromycin was non-inferior to intramuscular 
benzathine benzylpenicillin. 15 
 Mass drug administration (MDA) with azithromycin has been 
widely used as part of the WHO strategy for the elimination 
of trachoma as a public health problem. 16 Given the evidence 
of the safety of MDA with azithromycin and the efficacy of 
CMJv19n2-Marks.indd   159 3/4/19   8:26 PM
160 © Royal College of Physicians 2019. All rights reserved.
CME: Tropical Medicine
 10  World Health Organization Collaborating Center for Dracunculiasis 
Eradication .  Guinea worm wrap-up #253 .  Atlanta :  The Carter 
Center ,  2018 .  www.cartercenter.org/resources/pdfs/news/health_
publications/guinea_worm/wrap-up/253.pdf 
 11  World Health Organization Collaborating Center for Dracunculiasis 
Eradication .  Guinea worm wrap-up #256  .  Atlanta :  The Carter 
Center ,  2018 .  www.cartercenter.org/resources/pdfs/news/health_
publications/guinea_worm/wrap-up/256.pdf 
 12  Sreenivasan  N ,  Weiss  A ,  Djiatsa  J-P  et al .  Recurrence of Guinea 
worm disease in Chad after a 10-year absence: risk factors for 
human cases identified in 2010–2011 .  Am J Trop Med Hyg 
 2017 ; 97 : 575 – 82 . 
 13  Urrutia  RP ,  Merisier  D ,  Small  M  et al .  Unmet health needs  identified 
by Haitian women as priorities for attention: a qualitative study . 
 Reprod Health Matters  2012 ; 20 : 93 – 103 . 
 14  Asiedu  K ,  Amouzou  B ,  Dhariwal  A  et al .  Yaws eradication: 
past efforts and future perspectives .  Bull World Health Organ 
 2008 ; 86 : 499 - 499A . 
 15  Mitjà  O ,  Hays  R ,  Ipai  A  et al .  Single-dose azithromycin versus 
benzathine benzylpenicillin for treatment of yaws in children in 
Papua New Guinea: an open-label, non-inferiority, randomised trial . 
 Lancet  2012 ; 379 : 342 – 7 . 
 16  Emerson  PM ,  Burton  MJ ,  Solomon  AW ,  Bailey  R ,  Mabey  DC . 
 The SAFE strategy for trachoma control: using operational 
research for policy, and implementation .  Bull World Health Organ 
 2006 ; 84 : 613 – 9 . 
 17  The World Health Organization .  Eradication of yaws - the Morges 
Strategy .  Wkly Epidemiol Rec  2012 ; 87 : 189 – 194 . 
 18  Abdulai  AA ,  Agana-Nsiire  P ,  Biney  F  et al .  Community-based 
mass treatment with azithromycin for the elimination of 
yaws in Ghana – Results of a pilot study .  PLoS Negl Trop Dis 
 2018 ; 12 : e0006303 . 
 19  Marks  M ,  Vahi  V ,  Sokana  O  et al .  Impact of community mass treat-
ment with azithromycin for trachoma elimination on the preva-
lence of yaws .  PLoS Negl Trop Dis  2015 ; 9 : e0003988 . 
 20  Mitjà  O ,  Houinei  W ,  Moses  P  et al .  Mass treatment with single-dose 
azithromycin for yaws .  N Engl J Med  2015 ; 372 : 703 – 10 . 
 21  Mitjà  O ,  Godornes  C ,  Houinei  W  et al .  Re-emergence of yaws after 
single mass azithromycin treatment followed by targeted treat-
ment: a longitudinal study .  Lancet  2018 ; 391 : 1599 – 1607 . 
 22  Knauf  S ,  Gogarten  JF ,  Schuenemann  VJ  et al .  Nonhuman primates 
across sub-Saharan Africa are infected with the yaws bacterium 
 Treponema  pallidum subsp  pertenue .  Emerg Microbes Infect 
 2018 ; 7 : 157 . 
 23  Chuma  IS ,  Batamuzi  EK ,  Collins  DA   et al .  Widespread  Treponema 
 pallidum infection in nonhuman primates, Tanzania .  Emerg Infect 
Dis  2018 ; 24 : 1002 – 9 . 
Address for correspondence: Dr Michael Marks, London School 
of Hygiene and Tropical Medicine, Keppel Street, London 
WC1E 7HT, UK.
Email:  michael.marks@lshtm.ac.uk 
CMJv19n2-Marks.indd   160 3/4/19   8:26 PM
